Study guide
3.2 Spinal Shock vs. Neurogenic Shock Management
ABNN Certified Neuroscience Registered Nurse CNRN
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Neuroanatomy, Physiology, and Neurological Assessment
1.1 Central & Peripheral Nervous System Anatomy 1.2 Cerebral Circulation, Blood-Brain Barrier & CSF Dynamics 1.3 Comprehensive Neurological Assessment & GCS 1.4 Cranial Nerve Examination & Localization
2 Chapter 2: Neurotrauma & Increased Intracranial Pressure
2.1 Traumatic Brain Injury Pathophysiology & Classification 2.2 Intracranial Pressure Dynamics, Monro-Kellie & Monitoring 2.3 Management of Increased ICP & Herniation Syndromes 2.4 Secondary Brain Injury Prevention & ICU Care
3 Chapter 3: Spinal Cord Injury & Neurotrauma Management
3.1 Spinal Cord Injury Pathophysiology & ASIA Classification 3.2 Spinal Shock vs. Neurogenic Shock Management 3.3 Autonomic Dysreflexia Recognition & Emergency Protocols 3.4 SCI Acute Nursing Care, Mobilization & Complications
4 Chapter 4: Cerebrovascular Disorders - Ischemic Stroke & Interventions
4.1 Ischemic Stroke Pathophysiology, Penumbra & Vascular Syndromes 4.2 Acute Ischemic Stroke Assessment & NIHSS 4.3 Thrombolytic Therapy (tPA/Alteplase/Tenecteplase) Protocols 4.4 Endovascular Thrombectomy & Post-Procedure Management
5 Chapter 5: Cerebrovascular Disorders - Hemorrhagic Stroke & Vascular Malformations
5.1 Intracerebral Hemorrhage Pathophysiology, ICH Score & Acute Management 5.2 Subarachnoid Hemorrhage, Aneurysm Clipping/Coiling & Hunt-Hess Grading 5.3 Cerebral Vasospasm & Delayed Cerebral Ischemia (DCI) Management 5.4 Arteriovenous Malformations (AVMs), Cavernomas & Dural AV Fistulas
6 Chapter 6: Neurological Disorders - Seizures & Epilepsy
6.1 Seizure Classification, Etiology & Pathophysiology 6.2 Status Epilepticus Emergency Protocols & Algorithm 6.3 Antiepileptic Drug (AED) Pharmacology & Monitoring 6.4 Surgical Interventions & Epilepsy Patient Education
7 Chapter 7: Movement & Demyelinating Disorders
7.1 Parkinson's Disease & Movement Disorders 7.2 Multiple Sclerosis & Demyelinating Conditions 7.3 Amyotrophic Lateral Sclerosis & Neuromuscular Junction Disorders 7.4 Dementias, Normal Pressure Hydrocephalus & Neuro Pain Syndromes
8 Chapter 8: Central Nervous System Tumors & Neuro-Oncology
8.1 Primary Brain Tumors: Gliomas, Meningiomas & Acoustic Neuromas 8.2 Metastatic CNS Disease & Epidural Spinal Cord Compression 8.3 Neuro-Oncology Therapies: Surgery, Radiation, Chemo & Immunotherapy 8.4 Oncologic Emergencies, Symptom Management & Palliative Priorities
9 Chapter 9: CNS Infections & Inflammatory Conditions
9.1 Bacterial, Viral & Fungal Meningitis 9.2 Encephalitis, Brain Abscess & Prion Diseases 9.3 Guillain-Barré Syndrome & Autoimmune Neurologic Conditions 9.4 Neuro-Infectious ICU Monitoring & Isolation Protocols
10 Chapter 10: Neurodevelopmental & Pediatric Conditions
10.1 Neural Tube Defects & Spina Bifida 10.2 Pediatric Hydrocephalus & Cranial Malformations 10.3 Cerebral Palsy & Developmental Neurologic Management
11 Chapter 11: Professional Practice & Special Considerations in Neuroscience Nursing
11.1 Ethical Considerations & End-of-Life Care in Neuro ICU 11.2 Patient & Family Education Across Neuro Conditions 11.3 Interdisciplinary Care Coordination & Rehabilitation Transitions 11.4 Quality Improvement, Research & Evidence-Based Practice
3.2 Spinal Shock vs. Neurogenic Shock Management
Key Takeaways Explain This Topic AI
Spinal shock is a temporary neurological phenomenon characterized by flaccid paralysis and areflexia below the level of injury.
Neurogenic shock is a true hemodynamic emergency resulting from the loss of sympathetic tone, presenting with hypotension, bradycardia, and poikilothermia.
Neurogenic shock typically occurs in injuries at or above T6.
Management of neurogenic shock requires aggressive fluid resuscitation and the use of vasopressors with alpha and beta-adrenergic activity.
Last updated: July 2026
Spinal Shock vs. Neurogenic Shock
In the acute phase following a spinal cord injury, nurses must rapidly differentiate between two distinct but potentially concurrent shock states: spinal shock and neurogenic shock. While the terminology is sometimes confusingly interchanged in general practice, they describe fundamentally different physiological phenomena. One is a neurological deficit; the other is a life-threatening cardiovascular emergency.
Spinal Shock
Spinal shock is a temporary suppression of all reflex activity below the level of the spinal cord injury. It is a neurological phenomenon, not a hemodynamic one. The sudden mechanical transection or severe contusion of the cord abruptly halts the continuous descending facilitatory input from higher brain centers to the spinal cord segments below the injury.
Clinical Presentation
Flaccid Paralysis: Complete loss of voluntary motor control.
Areflexia: Absence of deep tendon reflexes (e.g., patellar, Achilles) and superficial reflexes.
Loss of Sensation: Complete anesthesia below the NLI.
Bowel and Bladder Dysfunction: Flaccid bowel and bladder, leading to urinary retention and paralytic ileus.
Duration and Resolution
Spinal shock begins within minutes of the injury. It is a transient state, lasting anywhere from a few days to several weeks. The exact duration is highly variable. The hallmark sign that spinal shock is resolving is the return of reflexes. Typically, the first reflex to return is the bulbocavernosus reflex (contraction of the anal sphincter in response to squeezing the glans penis or tugging on an indwelling Foley catheter). Following this, deep tendon reflexes return, often becoming hyperactive (spasticity), replacing the initial flaccid state.
Neurogenic Shock
Neurogenic shock is a form of distributive shock resulting from the sudden loss of autonomic (specifically sympathetic) nervous system signals to the smooth muscle in blood vessel walls. This loss of sympathetic tone leads to massive, unchecked vasodilation. It occurs almost exclusively in patients with spinal cord injuries at or above the T6 level. The sympathetic nervous system outflow originates from the thoracic and upper lumbar segments of the spinal cord (T1-L2). Injuries above T6 disrupt the communication between the vasomotor center in the brainstem and the sympathetic efferent nerves.
The Triad of Neurogenic Shock
The classic presentation of neurogenic shock involves three key signs:
Hypotension: Massive vasodilation creates a relative hypovolemia. The vascular space expands significantly, but the blood volume remains the same, leading to a precipitous drop in blood pressure and decreased venous return to the heart.
Bradycardia: The loss of sympathetic tone allows the parasympathetic nervous system (mediated by the vagus nerve, which originates in the brainstem and remains intact) to act unopposed. This unopposed vagal tone slows the heart rate, further compromising cardiac output.
Poikilothermia: The body loses its ability to regulate temperature. Peripheral vasodilation allows for rapid heat loss, and the patient's body temperature tends to equilibrate with the ambient room temperature. The inability to shiver below the level of injury also impairs heat generation.
- Feature Spinal Shock Neurogenic Shock
- Nature Neurological phenomenon Hemodynamic emergency (Distributive shock)
- Mechanism Loss of descending facilitatory tracts Loss of sympathetic vasomotor tone
- Level of Injury Can occur at any level Typically T6 and above
- Hemodynamics Normal (unless complicated by other trauma) Hypotension and Bradycardia
Reflexes Absent (Areflexia) Unaffected by this specific shock state (but absent due to concurrent spinal shock)
- Duration Days to weeks Typically lasts 1 to 3 weeks
- Hemodynamic Management of Neurogenic Shock
The immediate goal is to restore adequate perfusion to the spinal cord and other vital organs. Secondary ischemia must be prevented. The Mean Arterial Pressure (MAP) is closely monitored, with current guidelines recommending maintaining a MAP of 85-90 mmHg for the first 7 days post-injury to optimize spinal cord perfusion.
Fluid Resuscitation: Initial management involves intravenous crystalloid fluids (e.g., Normal Saline or Lactated Ringer's) to fill the expanded vascular space. However, caution is required. Because the underlying issue is vasodilation, not absolute fluid loss, excessive fluid administration can quickly lead to fluid overload and pulmonary edema, especially given the concurrent bradycardia and compromised cardiac function.
Vasopressors: If fluid resuscitation alone fails to achieve the target MAP, vasopressor therapy is initiated. The ideal agent should possess both alpha-adrenergic activity (to cause vasoconstriction and increase systemic vascular resistance) and beta-adrenergic activity (to increase heart rate and contractility, counteracting the bradycardia). Norepinephrine (Levophed) or Dopamine are commonly utilized first-line agents.
Atropine: Symptomatic bradycardia (e.g., causing a further drop in blood pressure or altered mental status) is treated with Atropine, a parasympatholytic agent that blocks vagal tone. In severe cases, a temporary pacemaker may be required.
Temperature Control: Patients must be actively warmed or cooled to maintain normothermia. The ambient room temperature should be carefully controlled.